未登录 A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida) 紫杉醇联合reparixin与单独紫杉醇作为转移性三阴性乳腺癌一线治疗的随机，安慰剂对照2期研究 (fRida) Goldstein, Lori J.; Mansutti, Mauro; Levy, Christelle; Chang, Jenny C.; Henry, Stephanie; Fernandez-Perez, Isaura; Prausova, Jana; Staroslawska, Elzbieta; Viale, Giuseppe; Butler, Beth; McCanna, Susan; Ruffini, Pier Adelchi; Wicha, Max S.; Schott, Anne F. 分享 收藏
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes Kubes, Jiri; Haas, Alexandra; Vondracek, Vladimir; Andrlik, Michal; Navratil, Matej; Slavikova, Silvia; Vitek, Pavel; Dedeckova, Katerina; Prausova, Jana; Ondrova, Barbora; Vinakurau, Stepan; Grebenyuk, Alexander; Dolezal, Tomas; Velackova, Barbora; Rosina, Jozef 分享 收藏
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study Yoshino, T.; Portnoy, D. C.; Obermannova, R.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T.; Garcia-Alfonso, P.; Cohn, A. L.; Van Cutsem, E.; Yamazaki, K.; Lonardi, S.; Muro, K.; Kim, T. W.; Yamaguchi, K.; Grothey, A.; O'Connor, J.; Taieb, J.; Wijayawardana, S. R.; Hozak, R. R.; Nasroulah, F.; Tabernero, J. 分享 收藏
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study Tabernero, J.; Hozak, R. R.; Yoshino, T.; Cohn, A. L.; Obermannova, R.; Bodoky, G.; Garcia-Carbonero, R.; Ciuleanu, T-E; Portnoy, D. C.; Prausova, J.; Muro, K.; Siegel, R. W.; Konrad, R. J.; Ouyang, H.; Melemed, S. A.; Ferry, D.; Nasroulah, F.; Van Cutsem, E. 分享 收藏
Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial Ruff, Paul; Van Cutsem, Eric; Lakomy, Radek; Prausova, Jana; van Hazel, Guy A.; Moiseyenko, Vladimir M.; Soussan-Lazard, Karen; Dochy, Emmanuelle; Magherini, Emmanuelle; Macarulla, Teresa; Papamichael, Demetris 分享 收藏
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study Rho, Young Soo; Gilabert, Marine; Polom, Karol; Aladashvili, Archil; Kopeckova, Katerina; Megdanova, Vera; Coleman, Niamh; Greally, Megan; Marrelli, Daniele; Roviello, Franco; McDermott, Ray; Petrova, Veneta; Mihaylova, Zhasmina; Bortlicek, Zbynek; Prausova, Jana; Batist, Gerald; Azoulay, Laurent; Kavan, Petr 分享 收藏
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progressionaEuro Obermannova, R.; Van Cutsem, E.; Yoshino, T.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T.; Garcia Alfonso, P.; Portnoy, D.; Cohn, A.; Yamazaki, K.; Clingan, P.; Lonardi, S.; Kim, T. W.; Yang, L.; Nasroulah, F.; Tabernero, J. 分享 收藏
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry Kopeckova, Katerina; Buchler, Tomas; Bortlicek, Zbynek; Hejduk, Karel; Chloupkova, Renata; Melichar, Bohuslav; Pokorna, Petra; Tomasek, Jiri; Linke, Zdenek; Petruzelka, Lubos; Kiss, Igor; Prausova, Jana 分享 收藏
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy Van Cutsem, Eric; Joulain, Florence; Hoff, Paulo M.; Mitchell, Edith; Ruff, Paul; Lakomy, Radek; Prausova, Jana; Moiseyenko, Vladimir M.; van Hazel, Guy; Cunningham, David; Arnold, Dirk; Schmoll, Hans-Joachim; ten Tije, Albert J.; McKendrick, Joseph; Kroening, Hendrik; Humblet, Yves; Gravalos, Cristina; Le-Guennec, Solenn; Andria, Michael; Dochy, Emmanuelle; Vishwanath, Raghu L.; Macarulla, Teresa; Tabernero, Josep 分享 收藏
Subgroup analysis by KRAS status in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression during or following first-line combination therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine Van Cutsem, E.; Obermannova, R.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T.; Garcia Alfonso, P.; Portnoy, D.; Cohn, A.; Yamazaki, K.; Clingan, P.; Yoshino, T.; Polikoff, J.; Lonardi, S.; Macarulla, T.; Yang, L.; Nasroulah, F. 分享 收藏
Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer Cohn, A. Lee; Yoshino, T.; Obermannova, R.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T. Eliade; Garcia-Alfonso, P.; Portnoy, D. C.; Van Cutsem, E.; Yamazaki, K.; Clingan, P. R.; Polikoff, J.; Lonardi, S.; Gao, L.; Yang, L.; Chang, S. C.; Ferry, D.; Nasroulah, F.; Tabernero, J. 分享 收藏
分享 收藏
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy Ruff, Paul; Ferry, David R.; Lakomy, Radek; Prausova, Jana; Van Hazel, Guy A.; Hoff, Paulo M.; Cunningham, David; Arnold, Dirk; Schmoll, Hans J.; Moiseyenko, Vladimir M.; McKendrick, Joseph J.; ten Tije, Albert J.; Vishwanath, Raghu L.; Bhargava, Pankaj; Chevalier, Soazig; Macarulla, Teresa; Van Cutsem, Eric 分享 收藏
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial Tabernero, Josep; Van Cutsem, Eric; Lakomy, Radek; Prausova, Jana; Ruff, Paul; van Hazel, Guy A.; Moiseyenko, Vladimir M.; Ferry, David R.; McKendrick, Joseph J.; Soussan-Lazard, Karen; Chevalier, Soazig; Allegra, Carmen J. 分享 收藏
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial Loehr, J. M.; Haas, S. L.; Bechstein, W. -O.; Bodoky, G.; Cwiertka, K.; Fischbach, W.; Foelsch, U. R.; Jaeger, D.; Osinsky, D.; Prausova, J.; Schmidt, W. E.; Lutz, M. P. 分享 收藏
Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC) Tabernero, J.; Van Cutsem, E.; Lakomy, R.; Prausova, J.; Ruff, P.; Van Hazel, G.; Moiseyenko, V.; Ferry, D.; McKendrick, J.; Soussan-Lazard, K.; Boelle, E.; Allegra, C. 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
